Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng Liang

Showing results (1121-1130 of 1,225) with videos related to

Pageof 123
Sort By:
Hepatology International|December 1, 2021
Towards a safe hospital: hepatitis C in-hospital micro-elimination program (HCV-HELP study)Jee-Fu Huang, Ming-Yen Hsieh, Yu-Ju Wei, et al.
Journal of Hepatology|December 3, 2014
Association of diabetes and PNPLA3 genetic variants with disease severity of patients with chronic hepatitis C virus infectionChung-Feng Huang, Chia-Yen Dai, Ming-Lun Yeh, et al.
Lung Cancer (Amsterdam, Netherlands)|February 8, 2018
EGFR-mediated interleukin enhancer-binding factor 3 contributes to formation and survival of cancer stem-like tumorspheres as a therapeutic target against EGFR-positive non-small cell lung cancerChun-Chia Cheng, Kuei-Fang Chou, Cheng-Wen Wu, et al.
Cancers|April 23, 2022
Circulating Let-7 Family Members as Non-Invasive Biomarkers for Predicting Hepatocellular Carcinoma Risk after Antiviral Treatment among Chronic Hepatitis C PatientsYi-Shan Tsai, Ching-I Huang, Pei-Chien Tsai, et al.
The Kaohsiung Journal of Medical Sciences|June 30, 2019
The prognostic factors between different viral etiologies among advanced hepatocellular carcinoma patients receiving sorafenib treatmentMing-Lun Yeh, Chung-Feng Huang, Ching-I Huang, et al.
The Kaohsiung Journal of Medical Sciences|July 10, 2020
Cure or curd: Modification of lipid profiles and cardio-cerebrovascular events after hepatitis C virus eradicationChung-Feng Huang, Chia-Yen Dai, Ming-Lun Yeh, et al.
Clinical and Molecular Hepatology|July 29, 2024
Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in TaiwanChung-Feng Huang, Chia-Yen Dai, Yi-Hung Lin, et al.
The Kaohsiung Journal of Medical Sciences|April 16, 2024
The efficacy of multi-disciplinary lifestyle modifications in Taiwanese nonalcoholic steatohepatitis patientsMing-Lun Yeh, Chia-Yen Dai, Chung-Feng Huang, et al.
Journal of Ethnopharmacology|May 2, 2024
Exploring the efficacy and mechanism of Bailing capsule to improve polycystic ovary syndrome in mice based on intestinal-derived LPS-TLR4 pathwayHao-Ru Guan, Bo Li, Ze-Hua Zhang, et al.
Nanotechnology|August 12, 2011
Full-field hard x-ray microscopy below 30 nm: a challenging nanofabrication achievementYu-Tung Chen, Tsung-Nan Lo, Yong S Chu, et al.
Pageof 123

Showing results (1121-1130 of 1,225) with videos related to

Sort By:
Pageof 123
Hepatology International|December 1, 2021
Towards a safe hospital: hepatitis C in-hospital micro-elimination program (HCV-HELP study)Jee-Fu Huang, Ming-Yen Hsieh, Yu-Ju Wei, et al.
Journal of Hepatology|December 3, 2014
Association of diabetes and PNPLA3 genetic variants with disease severity of patients with chronic hepatitis C virus infectionChung-Feng Huang, Chia-Yen Dai, Ming-Lun Yeh, et al.
Lung Cancer (Amsterdam, Netherlands)|February 8, 2018
EGFR-mediated interleukin enhancer-binding factor 3 contributes to formation and survival of cancer stem-like tumorspheres as a therapeutic target against EGFR-positive non-small cell lung cancerChun-Chia Cheng, Kuei-Fang Chou, Cheng-Wen Wu, et al.
Cancers|April 23, 2022
Circulating Let-7 Family Members as Non-Invasive Biomarkers for Predicting Hepatocellular Carcinoma Risk after Antiviral Treatment among Chronic Hepatitis C PatientsYi-Shan Tsai, Ching-I Huang, Pei-Chien Tsai, et al.
The Kaohsiung Journal of Medical Sciences|June 30, 2019
The prognostic factors between different viral etiologies among advanced hepatocellular carcinoma patients receiving sorafenib treatmentMing-Lun Yeh, Chung-Feng Huang, Ching-I Huang, et al.
The Kaohsiung Journal of Medical Sciences|July 10, 2020
Cure or curd: Modification of lipid profiles and cardio-cerebrovascular events after hepatitis C virus eradicationChung-Feng Huang, Chia-Yen Dai, Ming-Lun Yeh, et al.
Clinical and Molecular Hepatology|July 29, 2024
Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in TaiwanChung-Feng Huang, Chia-Yen Dai, Yi-Hung Lin, et al.
The Kaohsiung Journal of Medical Sciences|April 16, 2024
The efficacy of multi-disciplinary lifestyle modifications in Taiwanese nonalcoholic steatohepatitis patientsMing-Lun Yeh, Chia-Yen Dai, Chung-Feng Huang, et al.
Journal of Ethnopharmacology|May 2, 2024
Exploring the efficacy and mechanism of Bailing capsule to improve polycystic ovary syndrome in mice based on intestinal-derived LPS-TLR4 pathwayHao-Ru Guan, Bo Li, Ze-Hua Zhang, et al.
Nanotechnology|August 12, 2011
Full-field hard x-ray microscopy below 30 nm: a challenging nanofabrication achievementYu-Tung Chen, Tsung-Nan Lo, Yong S Chu, et al.
Pageof 123